Literature DB >> 29196474

Inflammasome activation and assembly at a glance.

Ankit Malik1, Thirumala-Devi Kanneganti2.   

Abstract

Inflammasomes are multimeric protein complexes that typically comprise a sensor, an adaptor and the zymogen procaspase-1. An inflammasome assembles in response to a diverse range of pathogen-associated or danger-associated molecular patterns (PAMPs or DAMPs). The inflammasome platform leads to activation of caspase-1 through proximity-induced self-cleavage, which further induces maturation of interleukins 1β and 18 (IL-1β and IL-18) through proteolytic cleavage of pro-IL-1β and pro-IL-18. Activated caspase-1 also cleaves gasdermin D, which leads to a particular form of cell death called pyroptosis. Mutations in genes that encode inflammasome components are associated with many inflammatory disorders, and studies in the past decade have highlighted the importance of appropriate activation of the inflammasome in homeostasis and disease pathogenesis. Therefore, much attention is being paid to uncover the modulators and regulators of inflammasome assembly and pyroptosis. This Cell Science at a Glance article and accompanying poster outlines the concepts in the activation of inflammasome sensors and assembly of the inflammasome platform. We also discuss recent insights into the mechanisms of regulation of inflammasome activity and the induction of cell death by pyroptosis.
© 2017. Published by The Company of Biologists Ltd.

Entities:  

Keywords:  Cell death; IL-1 cytokines; Inflammasome; Pyroptosis

Mesh:

Substances:

Year:  2017        PMID: 29196474      PMCID: PMC5769591          DOI: 10.1242/jcs.207365

Source DB:  PubMed          Journal:  J Cell Sci        ISSN: 0021-9533            Impact factor:   5.285


  159 in total

1.  Nlrp6- and ASC-Dependent Inflammasomes Do Not Shape the Commensal Gut Microbiota Composition.

Authors:  Michail Mamantopoulos; Francesca Ronchi; Filip Van Hauwermeiren; Sara Vieira-Silva; Bahtiyar Yilmaz; Liesbet Martens; Yvan Saeys; Stefan K Drexler; Amir S Yazdi; Jeroen Raes; Mohamed Lamkanfi; Kathy D McCoy; Andy Wullaert
Journal:  Immunity       Date:  2017-08-08       Impact factor: 31.745

2.  Innate immune detection of the type III secretion apparatus through the NLRC4 inflammasome.

Authors:  Edward A Miao; Dat P Mao; Natalya Yudkovsky; Richard Bonneau; Cynthia G Lorang; Sarah E Warren; Irina A Leaf; Alan Aderem
Journal:  Proc Natl Acad Sci U S A       Date:  2010-02-01       Impact factor: 11.205

Review 3.  Interferon-inducible Ifi200-family genes as modifiers of lupus susceptibility.

Authors:  Divaker Choubey
Journal:  Immunol Lett       Date:  2012-07-24       Impact factor: 3.685

4.  Molecular basis for specific recognition of bacterial ligands by NAIP/NLRC4 inflammasomes.

Authors:  Jeannette L Tenthorey; Eric M Kofoed; Matthew D Daugherty; Harmit S Malik; Russell E Vance
Journal:  Mol Cell       Date:  2014-03-20       Impact factor: 17.970

5.  The AIM2 inflammasome is essential for host defense against cytosolic bacteria and DNA viruses.

Authors:  Vijay A K Rathinam; Zhaozhao Jiang; Stephen N Waggoner; Shruti Sharma; Leah E Cole; Lisa Waggoner; Sivapriya Kailasan Vanaja; Brian G Monks; Sandhya Ganesan; Eicke Latz; Veit Hornung; Stefanie N Vogel; Eva Szomolanyi-Tsuda; Katherine A Fitzgerald
Journal:  Nat Immunol       Date:  2010-03-28       Impact factor: 25.606

6.  Caspase-11 protects against bacteria that escape the vacuole.

Authors:  Youssef Aachoui; Irina A Leaf; Jon A Hagar; Mary F Fontana; Cristine G Campos; Daniel E Zak; Michael H Tan; Peggy A Cotter; Russell E Vance; Alan Aderem; Edward A Miao
Journal:  Science       Date:  2013-01-24       Impact factor: 47.728

7.  A mutation in the Nlrp3 gene causing inflammasome hyperactivation potentiates Th17 cell-dominant immune responses.

Authors:  Guangxun Meng; Fuping Zhang; Ivan Fuss; Atsushi Kitani; Warren Strober
Journal:  Immunity       Date:  2009-06-04       Impact factor: 31.745

8.  NLRP6 negatively regulates innate immunity and host defence against bacterial pathogens.

Authors:  Paras K Anand; R K Subbarao Malireddi; John R Lukens; Peter Vogel; John Bertin; Mohamed Lamkanfi; Thirumala-Devi Kanneganti
Journal:  Nature       Date:  2012-08-16       Impact factor: 49.962

9.  Familial Mediterranean fever mutations lift the obligatory requirement for microtubules in Pyrin inflammasome activation.

Authors:  Hanne Van Gorp; Pedro H V Saavedra; Nathalia M de Vasconcelos; Nina Van Opdenbosch; Lieselotte Vande Walle; Magdalena Matusiak; Giusi Prencipe; Antonella Insalaco; Filip Van Hauwermeiren; Dieter Demon; Delfien J Bogaert; Melissa Dullaers; Elfride De Baere; Tino Hochepied; Joke Dehoorne; Karim Y Vermaelen; Filomeen Haerynck; Fabrizio De Benedetti; Mohamed Lamkanfi
Journal:  Proc Natl Acad Sci U S A       Date:  2016-11-22       Impact factor: 11.205

10.  An activating NLRC4 inflammasome mutation causes autoinflammation with recurrent macrophage activation syndrome.

Authors:  Scott W Canna; Adriana A de Jesus; Sushanth Gouni; Stephen R Brooks; Bernadette Marrero; Yin Liu; Michael A DiMattia; Kristien J M Zaal; Gina A Montealegre Sanchez; Hanna Kim; Dawn Chapelle; Nicole Plass; Yan Huang; Alejandro V Villarino; Angelique Biancotto; Thomas A Fleisher; Joseph A Duncan; John J O'Shea; Susanne Benseler; Alexei Grom; Zuoming Deng; Ronald M Laxer; Raphaela Goldbach-Mansky
Journal:  Nat Genet       Date:  2014-09-14       Impact factor: 38.330

View more
  126 in total

Review 1.  How the Respiratory Epithelium Senses and Reacts to Influenza Virus.

Authors:  Kambez H Benam; Laura Denney; Ling-Pei Ho
Journal:  Am J Respir Cell Mol Biol       Date:  2019-03       Impact factor: 6.914

Review 2.  Inflammasomes: a novel therapeutic target in pulmonary hypertension?

Authors:  Tara Elizabeth Scott; Barbara K Kemp-Harper; Adrian J Hobbs
Journal:  Br J Pharmacol       Date:  2018-06-27       Impact factor: 8.739

Review 3.  NLRP3 inflammasome in cancer and metabolic diseases.

Authors:  Bhesh Raj Sharma; Thirumala-Devi Kanneganti
Journal:  Nat Immunol       Date:  2021-03-11       Impact factor: 25.606

4.  HFD refeeding in mice after fasting impairs learning by activating caspase-1 in the brain.

Authors:  Albert E Towers; Maci L Oelschlager; Michal B Juda; Sparsh Jain; Stephen J Gainey; Gregory G Freund
Journal:  Metabolism       Date:  2019-11-05       Impact factor: 8.694

5.  Hydrogen sulfide mitigates myocardial inflammation by inhibiting nucleotide-binding oligomerization domain-like receptor protein 3 inflammasome activation in diabetic rats.

Authors:  Qiang Jia; Shomaila Mehmood; Xiaofen Liu; Shanfeng Ma; Rui Yang
Journal:  Exp Biol Med (Maywood)       Date:  2020-01-13

Review 6.  Finding intestinal fortitude: Integrating the microbiome into a holistic view of depression mechanisms, treatment, and resilience.

Authors:  M C Flux; Christopher A Lowry
Journal:  Neurobiol Dis       Date:  2019-08-24       Impact factor: 5.996

7.  Temporarily increased TGFβ following radon spa correlates with reduced pain while serum IL-18 is a general predictive marker for pain sensitivity.

Authors:  Miriam Kullmann; Paul F Rühle; Alexandra Harrer; Anna Donaubauer; Ina Becker; Renate Sieber; Gerhart Klein; Claudia Fournier; Rainer Fietkau; Udo S Gaipl; Benjamin Frey
Journal:  Radiat Environ Biophys       Date:  2018-11-19       Impact factor: 1.925

8.  TNF/TNFR axis promotes pyrin inflammasome activation and distinctly modulates pyrin inflammasomopathy.

Authors:  Deepika Sharma; Ankit Malik; Clifford Guy; Peter Vogel; Thirumala-Devi Kanneganti
Journal:  J Clin Invest       Date:  2018-11-19       Impact factor: 14.808

Review 9.  An update on cell intrinsic negative regulators of the NLRP3 inflammasome.

Authors:  Barun Poudel; Prajwal Gurung
Journal:  J Leukoc Biol       Date:  2018-01-26       Impact factor: 4.962

10.  Human monocyte transcriptional profiling identifies IL-18 receptor accessory protein and lactoferrin as novel immune targets in hypertension.

Authors:  Matthew R Alexander; Allison E Norlander; Fernando Elijovich; Ravi V Atreya; Amadou Gaye; Juan S Gnecco; Cheryl L Laffer; Cristi L Galindo; Meena S Madhur
Journal:  Br J Pharmacol       Date:  2018-06-21       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.